The report of this study follows all CONSORT Consolidated Standards of Reporting Trials recommendations for clinical test quality in parallel groups 29.
El informe del presente estudio seguirá las recomendaciones de CONSORT Consolidated Standards of Reporting Trials para la calidad de los ensayos clínicos con grupos en paralelo 29.